These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4760035)

  • 1. The effect of ethinyloestradiol on calcium and phosphorus metabolism of post-menopausal women with primary hyperparathyroidism.
    Gallagher JC; Wilkinson R
    Clin Sci Mol Med; 1973 Dec; 45(6):785-802. PubMed ID: 4760035
    [No Abstract]   [Full Text] [Related]  

  • 2. Some effects of ethinyl oestradiol on calcium and phosphorus metabolism in osteoporosis.
    Young MM; Jasani C; Smith DA; Nordin BE
    Clin Sci; 1968 Jun; 34(3):411-7. PubMed ID: 5666871
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment with with oestrogens of primary hyperparathyroidism in post-menopausal women.
    Gallagher JC; Nordin BE
    Lancet; 1972 Mar; 1(7749):503-7. PubMed ID: 4110019
    [No Abstract]   [Full Text] [Related]  

  • 4. Ethinyl estradiol and norethindrone in the treatment of primary hyperparathyroidism in postmenopausal women.
    Selby PL; Peacock M
    N Engl J Med; 1986 Jun; 314(23):1481-5. PubMed ID: 3754618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of ethinyl oestradiol on calcium and bone metabolism in peri- and postmenopausal women.
    Marshall RW; Selby PL; Chilvers DC; Hodgkinson A
    Horm Metab Res; 1984 Feb; 16(2):97-9. PubMed ID: 6706290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early effects of ethinyloestradiol and norethisterone treatment in post-menopausal women on bone resorption and calcium regulating hormones.
    Selby PL; Peacock M; Barkworth SA; Brown WB; Taylor GA
    Clin Sci (Lond); 1985 Sep; 69(3):265-71. PubMed ID: 3933891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevention and management of post-menopausal osteoporosis.
    Marshall DH; Horsman A; Nordin BE
    Acta Obstet Gynecol Scand Suppl; 1977; 65():49-56. PubMed ID: 269626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The activity of the bone isoenzyme of serum alkaline phosphatase and urinary hydroxyproline excretion in premenopausal and postmenopausal women with primary hyperparathyroidism.
    Broulik PD; Stĕpán J; Pacovský V
    Exp Clin Endocrinol; 1984 May; 83(3):315-9. PubMed ID: 6540700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic effects of synthetic salmon calcitonin in Paget's disease of bone.
    Avramides A; Baker RK; Wallach S
    Metabolism; 1974 Nov; 23(11):1037-46. PubMed ID: 4472557
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of calcium supplements on plasma alkaline phosphatase and urinary hydroxyproline in postmenopausal women.
    Horowitz M; Need AG; Philcox JC; Nordin BE
    Horm Metab Res; 1985 Jun; 17(6):311-2. PubMed ID: 4018720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary hydroxyproline concentration in primary hyperparathyroidism with and without renal stones.
    Sommer-Tsilenis E
    Eur Urol; 1977; 3(4):231-6. PubMed ID: 913450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of 1alpha-hydroxycholecalciferol and hormone therapy on the calcium balance of post-menopausal osteoporosis.
    Marshall DH; Gallagher JC; Guha P; Hanes F; Oldfield W; Nordin BE
    Calcif Tissue Res; 1977 May; 22 Suppl():78-84. PubMed ID: 334349
    [No Abstract]   [Full Text] [Related]  

  • 13. Conjugated estrogens in the treatment of postmenopausal women with hyperparathyroidism.
    Marcus R; Madvig P; Crim M; Pont A; Kosek J
    Ann Intern Med; 1984 May; 100(5):633-40. PubMed ID: 6324624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical effects of a calcium supplement in postmenopausal women with primary hyperparathyroidism.
    Horowitz M; Wishart JM; Need AG; Morris HA; Nordin BE
    Horm Metab Res; 1994 Jan; 26(1):39-42. PubMed ID: 8150422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimation of bone turnover evaluated by 47Ca-kinetics. Efficiency of serum bone gamma-carboxyglutamic acid-containing protein, serum alkaline phosphatase, and urinary hydroxyproline excretion.
    Charles P; Poser JW; Mosekilde L; Jensen FT
    J Clin Invest; 1985 Dec; 76(6):2254-8. PubMed ID: 3878367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute changes in calcium homeostasis during treatment of primary hyperparathyroidism with risedronate.
    Reasner CA; Stone MD; Hosking DJ; Ballah A; Mundy GR
    J Clin Endocrinol Metab; 1993 Oct; 77(4):1067-71. PubMed ID: 8408454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SPINAL OSTEOPOROSIS AND THE MENOPAUSE.
    JASANI C; NORDIN BE; SMITH DA; SWANSON I
    Proc R Soc Med; 1965 Jun; 58(6):441-4. PubMed ID: 14291272
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of oestrogen and progestogen therapy on calcium metabolism in post-menopausal women.
    Gallagher JC; Nordin EC
    Front Horm Res; 1975; 3():150-76. PubMed ID: 1234561
    [No Abstract]   [Full Text] [Related]  

  • 19. The relation between bone loss and calcium balance in women.
    Horsman A; Marshall DH; Nordin BE; Crilly RG; Simpson M
    Clin Sci (Lond); 1980 Aug; 59(2):137-42. PubMed ID: 7408419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of chlorothiazide on bone-related biochemical variables in normal post-menopausal women.
    Peh CA; Horowitz M; Wishart JM; Need AG; Morris HA; Nordin BE
    J Am Geriatr Soc; 1993 May; 41(5):513-6. PubMed ID: 8486884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.